EVMN · TickerCove

EVMNEvommune, Inc.Healthcare · Biotechnologyas of 2026-09-25

Horizon

Issued 2026-09-25 at $8.49 · now $8.49 (2026-09-25, +0.0% since)

Based on its own history, a month from the 2026-09-25 close, EVMN has typically landed between $5.32 and $12.00 — a range of −37.4% to +41.4% from the issuance price $8.49.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

200 overlapping 1 month windows · 2025-11-06 – 2026-08-26 · basis climatology · forecast (batch).

The cone is anchored at the 2026-09-25 issuance close ($8.49) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$8.49 · 0% of range

$8.49 low$31.57 high

Trailing 52 weeks to 2026-09-25 — factual context, not a signal.

Distribution ranges onlyiThis name has too little trading history to publish a calibrated probability, so we show its distribution ranges only — no directional call. Its record is still building.

No directional probability — ranges below.

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−5.5%

typical move · IQR 31.8%

−37.4%worst (p90)+41.4%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where EVMN has typically landed a month from the 2026-09-25 close of $8.49 — the range is history, not a prediction.

now $8.49 (+0.0%)
typical $8.02 (-5.5%)
middle 50% $6.67–$9.37
90% range $5.32–$12

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 200 windows spanning 2025-11-06 to 2026-09-25. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2026-06-26	−55.3%	−55.3%	+0.0%
2026-06-23	−53.3%	−53.3%	+3.8%
2026-06-25	−52.5%	−53.1%	+4.4%
3 best
2026-01-16	+71.0%	−0.8%	+87.9%
2026-01-15	+58.7%	−15.0%	+61.1%
2026-01-23	+58.2%	−11.7%	+67.3%

200 overlapping windows · 2025-11-06 – 2026-09-25 · not cherry-picked

Pending catalysts

October 2027 — Trial primary completion: Phase 2 primary completion: Study of EVO756 in Adults With Migraine (source, as of 2026-08-14)

Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-07-08	Carver Kyle	officer	Purchase	1,000 @ $13.26	$13K	+1.7% of holding	−2.1%	not yet — horizon still open	60,335	Form 4 · filed 2 days after the trade
2026-07-07	KIRSCH ARTHUR S	director	Purchase	10,000 @ $13.30	$133K	ownership Δ n/a	−5.4%	not yet — horizon still open	10,000	Form 4 · filed 1 day after the trade
2026-06-22	Drew Janice Suzann	officer	Sale	20,000 @ $22.63	$453K	−22.8% of holding	−49.9%	not yet — horizon still open	67,794	Form 4 · filed 2 days after the trade
2026-06-22	Pena Luis C.	director	Sale	7,438 @ $22.71	$169K	−1.2% of holding	−49.9%	not yet — horizon still open	630,458	Form 4 · filed 2 days after the trade
2026-06-22	Patel Jeegar Pravinkumar	officer	Sale	1,488 @ $22.50	$33K	−3.1% of holding	−49.9%	not yet — horizon still open	46,403	Form 4 · filed 2 days after the trade
2026-06-02	Cohen David E	director	Sale	5,456 @ $20.21	$110K	−23.1% of holding	−32.9%	not yet — horizon still open	18,209	Form 4 · filed 1 day after the trade
2026-06-02	Cohen David E	director	Sale	600 @ $21.38	$13K	−3.3% of holding	−32.9%	not yet — horizon still open	17,609	Form 4 · filed 1 day after the trade
2026-06-01	Pena Luis C.	director	Sale	16,787 @ $22.74	$382K	−2.6% of holding	−40.7%	not yet — horizon still open	637,896	Form 4 · filed 2 days after the trade
2026-06-01	Patel Jeegar Pravinkumar	officer	Sale	16,687 @ $22.74	$379K	−26.4% of holding	−40.7%	not yet — horizon still open	46,403	Form 4 · filed 2 days after the trade
2026-05-28	Carver Kyle	officer	Sale	18,175 @ $22.84	$415K	−23.4% of holding	−33.9%	not yet — horizon still open	59,335	Form 4 · filed 4 days after the trade
2026-05-28	Moss Gregory S.	director	Sale	14,223 @ $22.83	$325K	−18.9% of holding	−33.9%	not yet — horizon still open	60,835	Form 4 · filed 4 days after the trade
2025-12-19	Hopfner Robert Lorne	director	Purchase	1,000 @ $17.35	$17K	+33.0% of holding	+2.3%	+23.8%	4,026	Form 4 · filed 3 days after the trade
2025-11-07	Verduyn-van Weegen Felice Isabel	director	Purchase	1,562,500 @ $16.00	$25.0M	+46.4% of holding	−4.9%	+15.2%	4,929,633	Form 4 · filed 5 days after the trade
2025-11-07	LSP 7 Cooperative UA	director	Purchase	1,562,500 @ $16.00	$25.0M	+46.4% of holding	−4.9%	+15.2%	4,929,633	Form 4 · filed 5 days after the trade
2025-11-07	RA CAPITAL MANAGEMENT, L.P.	director	Purchase	1,157,096 @ $16.00	$18.5M	+76.3% of holding	−4.9%	+15.2%	2,674,425	Form 4 · filed 5 days after the trade
2025-11-07	RA CAPITAL MANAGEMENT, L.P.	director	Purchase	92,904 @ $16.00	$1.5M	+13.4% of holding	−4.9%	+15.2%	784,345	Form 4 · filed 5 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

169 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-06-22	Drew Janice Suzann	officer	Option exercise	16,161	87,794	Form 4
2026-06-22	Drew Janice Suzann	officer	Option exercise	3,839	71,633	Form 4
2026-06-22	Patel Jeegar Pravinkumar	officer	Option exercise	1,488	47,891	Form 4
2026-06-22	Patel Jeegar Pravinkumar	officer	Option exercise	1,488	27,842	Form 4
2026-06-22	Drew Janice Suzann	officer	Option exercise	3,839	53,795	Form 4
2026-06-22	Drew Janice Suzann	officer	Option exercise	16,161	39,321	Form 4
2026-06-02	Cohen David E	director	Award / grant	15,673	15,673	Form 4
2026-06-02	MCGRAW BENJAMIN F III	director	Award / grant	15,673	15,673	Form 4
2026-06-02	KIRSCH ARTHUR S	director	Award / grant	15,673	15,673	Form 4
2026-06-01	Patel Jeegar Pravinkumar	officer	Option exercise	13,512	63,090	Form 4
2026-06-01	Patel Jeegar Pravinkumar	officer	Option exercise	13,512	29,330	Form 4
2026-05-28	Carver Kyle	officer	Option exercise	15,000	77,510	Form 4
2026-05-28	Moss Gregory S.	director	Option exercise	14,223	75,058	Form 4
2026-05-28	Carver Kyle	officer	Option exercise	15,000	96,731	Form 4
2026-05-28	Moss Gregory S.	director	Option exercise	14,223	47,845	Form 4
2026-04-16	Bauer Eugene	director	Award / grant	51,117	51,117	Form 4
2026-04-16	Drew Janice Suzann	officer	Award / grant	73,892	73,892	Form 4
2026-04-16	Carver Kyle	officer	Award / grant	98,946	98,946	Form 4
2026-04-16	Pena Luis C.	director	Award / grant	291,420	291,420	Form 4
2026-04-16	Moss Gregory S.	director	Award / grant	115,279	115,279	Form 4
2026-04-16	Patel Jeegar Pravinkumar	officer	Award / grant	69,315	69,315	Form 4
2026-02-17	Verduyn-van Weegen Felice Isabel	director	Award / grant	358,680	5,288,313	Form 4
2026-02-17	LSP 7 Cooperative UA	director	Award / grant	358,680	5,288,313	Form 4
2026-02-17	RA CAPITAL MANAGEMENT, L.P.	director	Award / grant	35,868	2,710,293	Form 4
2025-12-09	Pena Luis C.	director	Withheld for tax	28,138	654,683	Form 4
2025-12-09	Moss Gregory S.	director	Withheld for tax	13,624	60,835	Form 4
2025-12-09	Carver Kyle	officer	Withheld for tax	13,290	62,510	Form 4
2025-12-09	Patel Jeegar Pravinkumar	officer	Withheld for tax	7,513	49,578	Form 4
2025-12-09	Drew Janice Suzann	officer	Withheld for tax	5,074	67,794	Form 4
2025-12-09	Bauer Eugene	director	Withheld for tax	1,478	270,818	Form 4
2025-12-08	Bauer Eugene	director	Award / grant	100,000	100,000	Form 4
2025-11-07	Drew Janice Suzann	officer	Conversion	12,500	0	Form 4
2025-11-07	LSP 7 Cooperative UA	director	Conversion	6,585,011	0	Form 4
2025-11-07	LSP 7 Cooperative UA	director	Conversion	3,367,133	3,367,133	Form 4
2025-11-07	LSP 7 Cooperative UA	director	Conversion	15,493,466	0	Form 4
2025-11-07	Verduyn-van Weegen Felice Isabel	director	Conversion	3,367,133	3,367,133	Form 4
2025-11-07	Verduyn-van Weegen Felice Isabel	director	Conversion	15,493,466	0	Form 4
2025-11-07	Verduyn-van Weegen Felice Isabel	director	Conversion	5,090,000	0	Form 4
2025-11-07	Verduyn-van Weegen Felice Isabel	director	Conversion	6,585,011	0	Form 4
2025-11-07	Drew Janice Suzann	officer	Conversion	1,587	72,868	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

27d remaining

2026-09-2610% elapsed2026-10-26

Logged immutably 2026-09-26; scored automatically on 2026-10-26 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.